Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 2 von 2162
Frontiers in immunology, 2021-07, Vol.12, p.686155-686155
2021
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
Ist Teil von
  • Frontiers in immunology, 2021-07, Vol.12, p.686155-686155
Ort / Verlag
Frontiers Media S.A
Erscheinungsjahr
2021
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
  • Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that mainly damages the hands and feet, which affects 0.5% to 1.0% of the population worldwide. With the sustained development of disease-modifying antirheumatic drugs (DMARDs), significant success has been achieved for preventing and relieving disease activity in RA patients. Unfortunately, some patients still show limited response to DMARDs, which puts forward new requirements for special targets and novel therapies. Understanding the pathogenetic roles of the various molecules in RA could facilitate discovery of potential therapeutic targets and approaches. In this review, both existing and emerging targets, including the proteins, small molecular metabolites, and epigenetic regulators related to RA, are discussed, with a focus on the mechanisms that result in inflammation and the development of new drugs for blocking the various modulators in RA.
Sprache
Englisch
Identifikatoren
ISSN: 1664-3224
eISSN: 1664-3224
DOI: 10.3389/fimmu.2021.686155
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_6ba7534632df4bd2bd6b926742e73fce

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX